WellDoc's new president embraces mobile health with innovative platform

By Admin
Written by Alyssa Clark While preparing to introduce its latest improvements to the youngest addition of the WellDoc app family, the organization has...

Written by Alyssa Clark

 

While preparing to introduce its latest improvements to the youngest addition of the WellDoc app family, the organization has implemented new president Kevin McRaith. WellDoc is embracing this seasoned bio-tech veteran due to his mhealth-oriented agenda; as the company finalizes preparations to roll out final touches to the highly-anticipated Bluestar platform this year. This platform is an FDA-approved mobile health application that is bent on improving patient engagement for people with Type 2 Diabetes.

The organization has already earned quite a bit of publicity for its recent accomplishments:

“In the run-up to commercialization of Bluestar later this year, WellDoc raised a $20 million Series A round led by the Merck Global Health Innovation Fund. In 2013, it launched a mobile diabetes intervention tool for physicians. Bluestar gives users real-time feedback based on the user’s personal health data in areas such as medications, blood sugar readings, diet and exercise. It also provides content to boost users’ health literacy and motivational support,” reports the New York Times.

Current WellDoc president Dr. Anand Iyer will take a new role as chief data science officer, which will boost the company’s analytics engine, according to a company-released statement.

With over 20 years of biotech industry experience and several product launches, Kevin McRaith’s recent hire demonstrates the industry-wide marriage between the pharmaceutical and mhealth worlds; an arrangement which has currently polarized industry experts in a heated debate. This hire also presents an interesting demonstration of these highly-debated market trends; by analyzing the meeting of these two different industries through McRaith’s acquisition, analysts suggest that the future of mobile technology within healthcare will be one where physicians prescribe just as many apps as they do medications.

 “Although the app is already in the market, available through employer plans at companies such as Ford and RiteAid, the hire reflects a bigger sales and marketing push by the mobile health company.”

 



 

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma